Back to discover
Drug

Poly(lactide)

Research stage
Emerging research

Also known as POLYLACTIDE.

RxNorm1424562UNII459TN2L5F5
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

In Vivo Evaluation of Thermally Drawn Biodegradable Optical Fibers as Brain Implants.

Research2025-03-01Journal of biomedical materials research. Part B, Applied biomaterials

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Poly(lactide)
Aliases & brands
POLYLACTIDE
RxNorm CUI
1424562
UNII
459TN2L5F5

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

In Vivo Evaluation of Thermally Drawn Biodegradable Optical Fibers as Brain Implants.

Journal of biomedical materials research. Part B, Applied biomaterials · 2025 · 1 cites
Recent papers

In Vivo Evaluation of Thermally Drawn Biodegradable Optical Fibers as Brain Implants.

Journal of biomedical materials research. Part B, Applied biomaterials · 2025 · 1 cites
Major research themes5
Absorbable Implants1Biocompatible Materials1Brain1Optical Fibers1Polyesters1
Journals, researchers & institutions
Top journals
  • Journal of biomedical materials research. Part B, Applied biomaterials1
Leading researchers
  • Abdollahian P1
  • Berg RW1
  • Li G1
  • Markos C1
  • Meneghetti M1
  • Sui K1
  • Wang J1
  • Wang Y1
Leading institutions
free-text, unnormalised
  • Copenhagen University1
  • Denmark Technical University1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature